跳至主要内容
临床试验/NCT01768325
NCT01768325已完成不适用

Evaluation of a New EUS-guided Needle (ProCore) Comparing to Conventional EUS-TCB Needle (Quick-Core); A Prospective Randomized, Controlled Multi-center Study.

Indiana University1 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2012年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
1
主要终点
Diagnostic Accuracy.

研究概览

简要总结

The purpose of this study is to evaluate a new EUS-guided biopsy needle (ProCore®) comparing it to conventional EUS-TCB needle (Quick-Core®) in the diagnosis of your suspicious disorder.

This study needle (ProCore®) is a new EUS-guided biopsy needle and has been recently approved by the U.S. Food and Drug Administration (FDA) for use.

详细描述

Primary Objective To compare the diagnostic accuracy of new EUS histology needle (19G, ProCore, Cook Medical Inc., Winston-Salem, NC) with the conventional histology needle (19G, Quick-Core, Cook Medical Inc., Winston-Salem, NC)

Secondary Objective To compare

  • The number of needle passes requiring to acquire adequate specimen
  • Length of core tissue obtained
  • Diagnostic contribution of immunohistochemical staining
  • Rates of complications

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Solid tumors ≥ 2 cm in size.

排除标准

  • •Thrombocytopenia

研究组 & 干预措施

EUS-Guided biopsy needle (ProCore)

Active Comparator

Comparison of ProCore core biopsy needle to QuickCore core biopsy needle.Cook Medical core biopsy needle.

  • The number of needle passes requiring to acquire adequate specimen
  • Length of core tissue obtained
  • Diagnostic contribution of immunohistochemical staining
  • Rates of complications

干预措施: EUS-Guided biopsy needle (ProCore) (Device)

EUS-TCB needle (Quick-Core)

Active Comparator

Comparison of core biopsy needles.

  • The number of needle passes requiring to acquire adequate specimen
  • Length of core tissue obtained
  • Diagnostic contribution of immunohistochemical staining
  • Rates of complications

干预措施: EUS-TCB needle (QuickCore) standard of care (Device)

结局指标

主要结局

Diagnostic Accuracy.

时间窗: 36 months

次要结局

  • Number of Needle Passes(36 months)
  • Overall Specimen Length(36 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of a New EUS-guided Needle (ProCore)... | 临床试验